TP53 and cancer: The enhancement of apoptosis was accompanied by increased NF-κB activation and was dependent on the expression of p53 target genes such as p21 and bax. Our results show that the p53 status in a cancer can affect the outcome of combination therapy with reovirus and chemotherapy drugs.